Executive Summary
An extraordinary cluster of 38 8-K filings on February 18, 2026, all disclosing executive or director changes under Item 5.02, spans diverse sectors including healthcare (7 companies), technology (6), energy/resources (5), and finance (4), signaling potential widespread leadership transitions possibly tied to proxy season or annual meetings. All filings carry neutral sentiment with no disclosed specifics on positions, names, appointment/resignation status, or reasons, averaging 4.4/10 materiality and 37% medium risk level across the group. 29% (11/38) include Regulation FD (Item 7.01) disclosures, suggesting material information released concurrently, while 8% (3/38) pair changes with results of operations (Item 2.02). No period-over-period trends, insider trading activity, forward-looking guidance, capital allocation details, financial ratios, or operational metrics are available in the enriched data, limiting quantitative comparisons but highlighting transparency gaps as a portfolio risk. Two filings from Sharing Economy International Inc. indicate repeated activity, and higher materiality outliers (6/10: Equinix, Greenlane Holdings, Teladoc) warrant priority. Overall implications: elevated governance uncertainty; investors should monitor Form 4s for insider reactions and press releases for context, as lack of details obscures conviction.
Tracking the trend? Catch up on the prior US Executive Officer Management Changes SEC digest from February 16, 2026.
Investment Signals(12)
- HF Sinclair Corp↓(BULLISH)▲
Low risk officer change paired with Item 2.02 results disclosure, neutral sentiment vs. medium risk peers
- Global Payments Inc↓(BULLISH)▲
Item 2.02 results and Reg FD alongside 5/10 materiality change, low risk signals stable transition
- Kraft Heinz Co↓(BULLISH)▲
Low risk, 3/10 materiality routine change, no elevated concerns vs. 37% medium risk cohort
- Madison Square Garden Sports Corp↓(BULLISH)▲
Low risk (4/10 materiality), routine disclosure with 137 KB exhibits, stable governance
- Tarsus Pharmaceuticals, Inc↓(BULLISH)▲
Low risk pharma peer amid 7 healthcare filings, 5/10 materiality neutral shift
- Health Catalyst, Inc↓(BULLISH)▲
Low risk with Reg FD disclosure in healthcare cluster, routine amid neutral sector sentiment
- California BanCorp↓(BULLISH)▲
Low risk finance sector peer (4/10 materiality), stable vs. broader churn
- Conagra Brands Inc↓(BULLISH)▲
Low risk food sector change (3/10 materiality), minimal impact in neutral environment
- SHARING ECONOMY INTERNATIONAL INC↓(BEARISH)▲
Medium risk, dual filings same day (186 KB + undisclosed), 5/10 materiality signals instability
- Equinix Inc↓(BEARISH)▲
Medium risk, top materiality 6/10 in tech cluster of 6, undisclosed details heighten uncertainty
- Teladoc Health, Inc↓(BEARISH)▲
Medium risk, 6/10 materiality with Reg FD, leadership flux in healthcare (7/38 filings)
- Greenlane Holdings, Inc↓(BEARISH)▲
Medium risk, peak 6/10 materiality, lack of details amplifies governance concerns
Risk Flags(10)
Dual 8-Ks same day, medium risk, unknown officer details could signal potential instability
- HF Sinclair Corp/Transparency↓[LOW-MEDIUM RISK]▼
Lack of specific officer details alongside Item 2.02 results could indicate leadership uncertainty
- Global Payments Inc/Governance↓[LOW RISK]▼
Undisclosed officer position/reason with 5/10 materiality, potential undisclosed issues
- Palladyne AI Corp/Instability↓[MEDIUM RISK]▼
Medium risk, no details on key position or change type in AI sector
- Ankam, Inc/Undisclosed Issues↓[MEDIUM RISK]▼
Medium risk, lack of details on appointment/resignation could signal governance problems
- Equinix Inc/High Materiality Risk↓[MEDIUM RISK]▼
Medium risk at 6/10 materiality, unknown reasons for change in data center leader
- Greenlane Holdings, Inc/Uncertainty↓[MEDIUM RISK]▼
Medium risk, 6/10 materiality with no specifics on impacted role
- Teladoc Health, Inc/Transition Risk↓[MEDIUM RISK]▼
Medium risk, 6/10 materiality, leadership uncertainty in telehealth
- Jaguar Uranium Corp/Dilution↓[MEDIUM RISK]▼
Medium risk officer change + Item 3.02 unregistered equity sales, potential dilution
- Liqtech International Inc/Governance↓[MEDIUM RISK]▼
Medium risk, undisclosed details could hide departure reasons or comp issues
Opportunities(8)
- MVB Financial Corp/Succession Planning↓(OPPORTUNITY)◆
Explicit note on potential positive succession if internal promotion, low risk with Reg FD
- HF Sinclair Corp/Earnings Synergy↓(OPPORTUNITY)◆
Low risk change with Item 2.02 results, opportunity to assess leadership continuity post-earnings
- Global Payments Inc/Reg FD Catalyst↓(OPPORTUNITY)◆
Low risk, Item 7.01 disclosure alongside change offers alpha from material info release
- Health Catalyst, Inc/Healthcare Stability↓(OPPORTUNITY)◆
Low risk in 7-filing healthcare cluster, potential undervalued stability play
- California BanCorp/Finance Low Risk↓(OPPORTUNITY)◆
Low risk in stable finance group (4/38), routine change supports relative outperformance
- LiveRamp Holdings, Inc/Tech Routine↓(OPPORTUNITY)◆
Low risk 3/10 materiality in tech cluster, opportunity for dip-buy if details benign
- RPC Inc/Amendment Clarity↓(OPPORTUNITY)◆
8-K/A filing low risk, potential positive update on prior disclosure
- Washington Trust Bancorp/Low Exposure↓(OPPORTUNITY)◆
Lowest materiality 3/10 in finance, minimal churn impact for long positions
Sector Themes(6)
- Healthcare/Pharma Leadership Flux◆
7/38 filings (Palladyne AI, Tarsus, Sintx, Phio, Health Catalyst, Charles River, Teladoc), avg materiality 4.7/10, 43% medium risk; potential sector-wide transitions amid neutral sentiment, watch for biotech funding impacts
- Technology/Data Center Turnover◆
6/38 (Global Payments, Equinix, Formfactor, Remitly, LiveRamp, Atlassian), avg materiality 4.5/10, 33% medium risk + 50% Reg FD; signals possible talent shifts in high-growth tech, relative to low-risk peers
- Finance Sector Relative Stability◆
4/38 (Washington Trust, California BanCorp, MVB, American Financial), all low risk, avg 3.5/10 materiality; contrasts broader 37% medium risk, supports defensive positioning
- Energy/Resources Churn◆
5/38 (HF Sinclair, RPC, Coeur Mining, One Gas, Jaguar Uranium), avg materiality 4/10, 20% medium risk + Item 2.02 in 2; commodity volatility may drive changes, 23MB exhibits in Coeur suggest detail-rich
- Repeated Disclosures Pattern◆
3% (2/38 from Sharing Economy Int'l), both medium risk 5/10 materiality; outlier indicating ongoing instability vs. single-filings norm
- Reg FD Concentration◆
29% (11/38) pair changes with Item 7.01, skewed to tech/health (64%), avg materiality 4.6/10; theme of material info dumps, potential short-term catalysts
Watch List(8)
Dual 8-Ks (AccNo 0001213900-26-017657 & -017648), medium risk, monitor Form 4s and PRs for details on repeated changes
6/10 materiality medium risk in tech, watch for position specifics and insider activity post-Feb 18
Medium risk 6/10 materiality with Item 7.01, track healthcare cluster follow-ups
6/10 materiality medium risk, monitor for governance updates in consumer space
Low risk but 23 MB filing with Item 2.02, watch detailed exhibits for quant metrics on change
Medium risk with Item 3.02 dilution, monitor insider holdings and mining sector peers
- Companies with Item 5.07 (Simulations Plus, Central Garden & Pet)👁
Vote results + changes, watch AGM outcomes for board conviction
- 11 Reg FD Filers (e.g., Palladyne, Formfactor, One Gas)👁
Material disclosures sans details, track earnings calls or PRs for guidance/insider patterns
Filing Analyses(38)
18-02-2026
SHARING ECONOMY INTERNATIONAL INC. filed an 8-K on February 18, 2026 (AccNo: 0001213900-26-017657), disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. Specific details including the key position affected, individual names, appointment or resignation status, reasons for change, and timing are NOT_DISCLOSED. No financial metrics, performance comparisons, or other quantitative data are provided in the filing summary.
- ·File size: 186 KB
18-02-2026
HF Sinclair Corp filed an 8-K on February 18, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific details on the officer involved, position, reason for change, or any financial metrics are disclosed in the provided filing information. No positive or negative metrics, comparisons, or impacts are mentioned.
18-02-2026
SHARING ECONOMY INTERNATIONAL INC. filed an 8-K on February 18, 2026 (AccNo: 0001213900-26-017648), disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals involved, reasons for change, or any quantitative metrics are disclosed.
18-02-2026
GLOBAL PAYMENTS INC filed an 8-K on 2026-02-18 disclosing results of operations and financial condition (Item 2.02), departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements (Item 5.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). Specific details on the officer change, including position, appointment or resignation, reasons, financial metrics, or performance comparisons are NOT_DISCLOSED.
18-02-2026
Palladyne AI Corp. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, appointment or resignation status, reasons for change, or any financial metrics are disclosed. Sector not specified.
18-02-2026
Kraft Heinz Co filed an 8-K on February 18, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individual names, nature of change (appointment or resignation), reasons, timing, or any quantitative data such as compensation amounts are disclosed in the provided filing information. No positive or negative governance implications, board outcomes, or market impacts can be assessed due to lack of details.
18-02-2026
Ankam, Inc. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, and any governance implications are NOT_DISCLOSED. No quantitative metrics, financial data, or scheduled events are mentioned.
18-02-2026
Madison Square Garden Sports Corp. filed an 8-K on February 18, 2026 (AccNo: 0001193125-26-056081, Size: 137 KB), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on the affected position, individuals involved, reasons for the change, or any quantitative metrics are disclosed. No positive or negative impacts are specified, resulting in neutral informational disclosure.
18-02-2026
Tarsus Pharmaceuticals, Inc. disclosed an officer change via 8-K filing on February 18, 2026, under Item 5.02 covering departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, or terms are disclosed.
18-02-2026
Sintx Technologies, Inc. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, names, reasons, or timing were disclosed.
- ·AccNo: 0001493152-26-007271
- ·File Size: 367 KB
- ·Sector: NOT_DISCLOSED
18-02-2026
Health Catalyst, Inc. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, appointment or resignation, reasons, or any quantitative metrics are provided. No positive or negative performance metrics, changes, or scheduled events are mentioned.
18-02-2026
Washington Trust Bancorp Inc filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. No specific details on the key position affected, individuals involved, reasons for the change, timing, or compensatory arrangements are disclosed in the provided information. No quantitative financial metrics, performance comparisons, or other material data points are mentioned.
- ·AccNo: 0000737468-26-000031
- ·File Size: 165 KB
- ·Sector: not specified
18-02-2026
Simulations Plus, Inc. filed an 8-K on February 18, 2026, reporting under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers; under Item 5.07 submission of matters to a vote of security holders; and under Item 9.01 financial statements and exhibits. No specific details such as names, titles, reasons for changes, timing, or quantitative impacts are disclosed. No positive or negative metrics, financial data, or scheduled events were mentioned.
18-02-2026
Equinix Inc (EQIX) filed an 8-K on February 18, 2026, disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the affected position, individual names, reasons for change, or effective dates are disclosed in the provided filing summary.
18-02-2026
CENTRAL GARDEN & PET CO filed an 8-K on 2026-02-18 disclosing matters under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). Specific details on the officer or director change, including key position, appointment/resignation status, reasons, timing, board composition impact, or vote outcomes, are NOT_DISCLOSED. No quantitative metrics, financial data, scheduled events, or governance implications are explicitly stated.
- ·AccNo: 0001193125-26-057026
- ·Filing size: 324 KB
- ·Event date: 2026-02-18
18-02-2026
FormFactor Inc filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the officer's name, position, appointment or resignation status, reasons, or timing provided. No quantitative financial metrics, performance comparisons, or other material changes mentioned.
18-02-2026
Werner Enterprises Inc filed an 8-K on 2026-02-18 disclosing under Item 5.02 matters related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, names, reasons for changes, or quantitative impacts are provided.
- ·Filing Accession Number: 0000793074-26-000049
- ·File size: 167 KB
- ·Sector: not specified
18-02-2026
Remitly Global, Inc. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits are included. No specific details on the affected officer, position, appointment or resignation status, reasons, or timing are disclosed.
18-02-2026
Phio Pharmaceuticals Corp. filed a Form 8-K on February 18, 2026 (AccNo: 0001437749-26-004542), disclosing information under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, positions affected, reasons for changes, timing details, or quantitative data such as compensation amounts are disclosed in the provided filing summary. Sector is not specified.
18-02-2026
RPC INC filed an 8-K on 2026-02-18 (AccNo: 0001104659-26-017066) under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as affected positions (e.g., CEO, CFO), names of individuals, appointment or resignation status, reasons for change, effective dates, or governance impacts are provided. No quantitative data, financial metrics, or scheduled events mentioned.
18-02-2026
YUNHONG GREEN CTI LTD. filed an 8-K on 2026-02-18 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, names of individuals, reasons for the change, timing, or any quantitative data such as compensation amounts are disclosed. Sector information is not specified.
18-02-2026
RE/MAX Holdings, Inc. filed an 8-K on February 18, 2026, disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with no specific details on position, appointment/resignation, or reasons provided. The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No quantitative financial metrics, performance comparisons, or governance impacts are disclosed.
18-02-2026
Greenlane Holdings, Inc. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on affected positions, individuals, reasons, or timing are disclosed.
18-02-2026
ONE Gas, Inc. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, names of individuals, appointment or resignation status, reasons for the change, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
18-02-2026
California BanCorp (CA) filed an 8-K on 2026-02-18 disclosing officer or director changes under Item 5.02, which covers departures, elections, appointments, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific names, positions, reasons, financial metrics, or other quantitative details are disclosed.
18-02-2026
Trulieve Cannabis Corp. filed an 8-K on 2026-02-18 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key positions affected, individuals involved, reasons for change, timing, or any quantitative impacts are disclosed. This is a routine SEC disclosure for leadership changes with no additional context provided.
18-02-2026
Teladoc Health, Inc. filed an 8-K on 2026-02-18 disclosing an officer change or related matter under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), along with Regulation FD disclosure under Item 7.01 and exhibits under Item 9.01. No specific details on the affected officer, position, appointment or resignation status, reasons, or timing are disclosed. No financial metrics, performance comparisons, or quantitative data are mentioned.
18-02-2026
Coeur Mining, Inc. filed an 8-K on February 18, 2026 (AccNo: 0001140361-26-006019, Size: 23 MB), triggering Items 2.02 (Results of Operations and Financial Condition), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details on the officer change, including position, name, reason, appointment/resignation status, financial metrics, or results of operations are disclosed in the provided information. No quantitative data, period-over-period comparisons, or scheduled events are mentioned.
18-02-2026
LiveRamp Holdings, Inc. filed an 8-K on 2026-02-18 under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative terms are disclosed in the provided filing information. This is a routine governance disclosure with no additional financial or operational metrics mentioned.
18-02-2026
LIQTECH INTERNATIONAL INC filed an 8-K on 2026-02-18 disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, names of individuals, appointment or resignation status, reasons for the change, and any timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
18-02-2026
Charles River Laboratories International, Inc. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections, appointments, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the affected officers, reasons for change, or quantitative impacts are disclosed.
18-02-2026
Conagra Brands Inc. filed an 8-K on February 18, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any financial metrics are disclosed in the provided information.
18-02-2026
MVB Financial Corp filed an 8-K on February 18, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, or any financial metrics are disclosed. The filing appears routine with no quantified positive or negative impacts mentioned.
18-02-2026
AMERICAN FINANCIAL GROUP INC filed an 8-K on 2026-02-18 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on individuals, positions, reasons, or quantitative impacts are disclosed.
18-02-2026
Jaguar Uranium Corp. filed an 8-K on February 18, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. The filing also covers Item 3.02 (Unregistered Sales of Equity Securities), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details on positions affected, individuals involved, reasons for changes, or financial metrics are disclosed.
18-02-2026
Atlassian Corp filed an 8-K on 2026-02-18 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or effective dates are disclosed. No quantitative metrics, financial impacts, or performance comparisons are mentioned.
18-02-2026
NewMarket Corp filed an 8-K on 2026-02-18 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on affected positions, names, reasons for change, timing, or any quantitative data are disclosed. No positive or negative metrics, financial impacts, or governance implications are provided in the filing summary.
18-02-2026
ALTISOURCE PORTFOLIO SOLUTIONS S.A. filed an 8-K on 2026-02-18 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01) and Other Events (Item 8.01). Specific details including the key position affected, whether it is an appointment or resignation, the officer's name, reason for change, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.
Get daily alerts with 12 investment signals, 10 risk alerts, 8 opportunities and full AI analysis of all 38 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Corporate Distress Financial Stress SEC Filings — March 24, 2026
US Corporate Distress Financial Stress SEC Filings